过敏性鼻炎治疗市场：依治疗类型、给药途径、通路及地区划分

2025 年全球过敏性鼻炎治疗市场规模估计为 169.1 亿美元，预计到 2032 年将达到 238.1 亿美元，2025 年至 2032 年的复合年增长率为 5.0%。

数字。 2025 年过敏性鼻炎治疗市场占有率（按地区划分）

过敏性鼻炎，俗称花粉症，是身体对一种或多种空气传播的过敏原（如花粉或灰尘）的发炎反应。它会引起打喷嚏、流鼻水、鼻塞和眼睛发痒等症状。近年来，由于环境污染加剧、生活方式改变等因素，全球过敏性鼻炎的盛行率稳定上升。据估计，目前全球约有10-30％的人口患有过敏性鼻炎，这是一个重大的健康问题。由于人们对过敏性鼻炎认识的不断提高和诊断水平的提高，过敏性鼻炎药物的市场也在大幅增长。

市场动态：

全球过敏性鼻炎治疗市场的成长受到全球过敏性鼻炎患者盛行率上升的推动。此外，由于环境污染程度加剧和天气模式变化导致花粉等空气过敏原激增，市场正在经历强劲成长。诊断和治疗方法的进步以及製药公司在过敏研究方面的投入增加，推动了新产品的推出，从而促进了市场成长。然而，重磅药物品牌专利到期及学名药的出现预计将在一定程度上阻碍创新药製造商的成长。然而，印度和中国等人口众多且患有过敏症的新兴经济体可能会在未来几年为市场参与者提供有利可图的机会。

本研究的主要特点

• 本报告对全球过敏性鼻炎治疗市场进行了详细分析，并提供了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%），假设 2024 年为基准年。
• 它还强调了各个领域的潜在收益成长机会，并说明了该市场的引人注目的投资提案矩阵。
• 它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
• 全球过敏性鼻炎治疗市场的主要企业根据公司亮点、产品系列、关键亮点、绩效和策略等参数进行分析。
• 主要公司包括默克公司、勃林格殷格翰国际有限公司、阿斯特捷利康公司、葛兰素史克公司、强生服务公司、梯瓦製药工业有限公司、诺华公司、迈兰公司、Aytu BioPharma 公司、再生元製药公司、Revolo Biotherapeutics、雷迪欧实验室有限公司、Glenmark 製药有限公司、拜耳药厂、Alembic 有限公司。
• 本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
• 全球过敏性鼻炎治疗市场迎合了该行业的各种相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员可以透过用于分析全球过敏性鼻炎治疗市场的各种策略矩阵来促进决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 影响分析
• 市场趋势
• 主要进展
• 监管情景
• 管道分析
• 流行病学
• 收购和合作场景
• 产品发布/核准
• 品牌与价格分析
• 资金筹措和投资
• PEST分析
• 波特的分析

4. 全球过敏性鼻炎治疗市场 - 冠状病毒 (COVID-19) 大流行的影响

• 整体影响
• 政府倡议
• COVID-19 市场影响

5. 2020 年至 2032 年全球过敏性鼻炎治疗市场（按治疗类型划分）（十亿美元）

• 免疫疗法
• 皮下免疫治疗 (SCIT)
• 舌下免疫治疗 (SLIT)
• 抗组织胺药
• 减充血剂
• 白三烯受体拮抗剂
• 皮质类固醇
• 其他的

6. 2020 年至 2032 年全球过敏性鼻炎治疗市场（依给药途径划分）（十亿美元）

• 口服
• 鼻腔
• 眼
• 其他的

7. 2020 年至 2032 年全球过敏性鼻炎治疗市场按分销管道划分（十亿美元）

• 医院药房
• 零售药局
• 电子商务

8. 2020 年至 2032 年全球过敏性鼻炎治疗市场（按地区划分）（十亿美元）

• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第九章 竞争格局

• 公司简介
  • Merck &Co., Inc.
  • Boehringer Ingelheim International GmbH
  • AstraZeneca
  • GSK plc.
  • Johnson &Johnson Services, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Mylan NV
  • Aytu BioPharma, Inc.
  • Regeneron Pharmaceuticals Inc.
  • Revolo Biotherapeutics
  • Dr. Reddy's Laboratories Ltd
  • Glenmark Pharmaceuticals Ltd
  • Bayer AG
  • Alembic Pharmaceuticals Limited
  • Sanofi
  • Hikma Pharmaceuticals PLC

第 10 章 分析师观点

第 11 章 参考文献与调查方法

• 参考
• 调查方法

Global Allergic Rhinitis Treatment Market is estimated to be valued at USD 16.91 Bn in 2025 and is expected to reach USD 23.81 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.0% from 2025 to 2032.

Figure. Allergic Rhinitis Treatment Market Share (%), By Region 2025

Allergic rhinitis, commonly known as hay fever, is a condition where the body exhibits an inflammatory response to one or more airborne allergens like pollen or dust. It causes symptoms like sneezing, runny nose, nasal congestion and itchy eyes. The global prevalence of allergic rhinitis has been steadily increasing in recent years due to factors like increasing environmental pollution and changes in lifestyle. According to some estimates, about 10-30% of the global population currently suffers from allergic rhinitis, making it a major health concern. With growing awareness and better diagnosis, the market for drugs to treat allergic rhinitis has also expanded significantly.

Market Dynamics:

The global allergic rhinitis treatment market is driven by the rising prevalence of allergic rhinitis cases globally. The market has also witnessed robust growth due to the increasing environmental pollution levels and changing climate patterns which have led to the proliferation of airborne allergens like pollen. Advancements in diagnosis and treatment options along with higher investments in allergy research by pharmaceutical companies are translating into new product launches and boosting the market growth. However, patent expiries of blockbuster drug brands coupled with the availability of generic alternatives are expected to hamper the growth of innovator drug makers to some extent. Nevertheless, emerging economies like India and China with their huge population base suffering from allergies present lucrative opportunities for market players in the coming years.

Key Features of the Study:

• This report provides an in-depth analysis of the global allergic rhinitis treatment market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global allergic rhinitis treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this includes Merck & Co., Inc., Boehringer Ingelheim International GmbH, AstraZeneca, GSK plc., Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Mylan N.V., Aytu BioPharma, Inc., Regeneron Pharmaceuticals Inc., Revolo Biotherapeutics, Dr. Reddy's Laboratories Ltd, Glenmark Pharmaceuticals Ltd, Bayer AG, Alembic Pharmaceuticals Limited, Sanofi, Hikma Pharmaceuticals PLC.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global allergic rhinitis treatment market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global allergic rhinitis treatment market.

Detailed Segmentation-

• By Treatment Type:
  • Immunotherapy
  • Sub-cutaneous Immunotherapy (SCIT)
  • Sub-lingual Immunotherapy (SLIT)
  • Anti-histamines
  • Decongestants
  • Leukotriene Receptor Antagonists
  • Corticosteroids
  • Others
• By Route of Administration:
  • Oral
  • Nasal
  • Intraocular
  • Others
• By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • E-commerce
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • AstraZeneca
  • GSK plc.
  • Johnson & Johnson Services, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Mylan N.V.
  • Aytu BioPharma, Inc.
  • Regeneron Pharmaceuticals Inc.
  • Revolo Biotherapeutics
  • Reddy's Laboratories Ltd
  • Glenmark Pharmaceuticals Ltd
  • Bayer AG
  • Alembic Pharmaceuticals Limited
  • Sanofi
  • Hikma Pharmaceuticals PLC

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Treatment Type
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Pipeline Analysis
• Epidemiology
• Acquisitions and Partnerships Scenario
• Product Launches/Approvals
• Brand and Pricing Analysis
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Allergic Rhinitis Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Allergic Rhinitis Treatment Market, By Treatment Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Immunotherapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Sub-cutaneous Immunotherapy (SCIT)
• Sub-lingual Immunotherapy (SLIT)
• Anti-histamines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Decongestants
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Leukotriene Receptor Antagonists
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Corticosteroids
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Allergic Rhinitis Treatment Market, By Route of Administration, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Oral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Nasal
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Intraocular
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Allergic Rhinitis Treatment Market, By Distribution Channel, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• E-commerce
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Allergic Rhinitis Treatment Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Merck & Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boehringer Ingelheim International GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • AstraZeneca
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • GSK plc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Johnson & Johnson Services, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Mylan N.V.
  • Aytu BioPharma, Inc.
  • Regeneron Pharmaceuticals Inc.
  • Revolo Biotherapeutics
  • Dr. Reddy's Laboratories Ltd
  • Glenmark Pharmaceuticals Ltd
  • Bayer AG
  • Alembic Pharmaceuticals Limited
  • Sanofi
  • Hikma Pharmaceuticals PLC

10. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact